Yahoo Sports College Expert Cassandra Negley explains why UConn freshman Paige Bueckers is the player to watch during the 2021 Women’s NCAA Tournament, and predicts how far Bueckers can take the Huskies this year.
Yahoo Sports College Expert Cassandra Negley explains why UConn freshman Paige Bueckers is the player to watch during the 2021 Women’s NCAA Tournament, and predicts how far Bueckers can take the Huskies this year.
Grupo Televisa , Mexico's largest broadcaster, trimmed its losses in the first quarter this year, it reported on Thursday, driven by profit from partnerships and reduced financial expenses. The company posted a net loss of 584 million pesos ($29 million) in the January-to-March period, compared to a steeper net loss of 9.7 billion pesos the same period a year earlier. Televisa reported quarterly revenue of 23.9 billion pesos, up 2.6% year-on-year.
People’s Bank of Commerce (OTCBB: PBCO) announced today its financial results for the first quarter of 2021. The bank reported net income of $2,892,000, or $0.73 per diluted share, for the first quarter of 2021 compared to net income of $1,111,000, or $0.33 per diluted share, in the same quarter of 2020. First quarter earnings in 2021 were impacted by the one-time, non-recurring merger accounting adjustments with Willamette Community Bank totaling $527 thousand or $0.10 per diluted share. Earnings per share for the trailing 12 months were $2.17 per share up from $1.36 per share for the same period of 2020, or a 59% increase.
Ten women spoke to the Los Angeles Times about alleged abuses and mistreatment under former coach Lori Nelson, which calls to mind other instances of how terribly young women have been treated in the sports world.
CALGARY, Alberta, April 22, 2021 (GLOBE NEWSWIRE) -- CORDY OILFIELD SERVICES INC. (the “Corporation” or “Cordy”) (CKK: TSX-V) released today its fourth quarter and 2020 annual results. Three months ended December 31 Twelve months ended December 31($ 000's)20202019($) Change 20202019($) ChangeRevenue Environmental Services5,707 3,450 2,257 18,264 15,834 2,430 Heavy Construction25 102 (77) 297 516 (219)Corporate- - - 15 5 10 5,732 3,552 2,180 18,576 16,355 2,221 Direct operating expenses Environmental Services4,344 3,231 1,113 13,491 12,561 930 Heavy Construction20 66 (46) 138 297 (159)Corporate- - - - - - 4,364 3,297 1,067 13,629 12,858 771 General and administrative expenses Environmental Services144 169 (25) 655 756 (101)Heavy Construction- - - 2 2 - Corporate355 197 158 983 921 62 499 366 133 1,640 1,679 (39)Operating earnings (loss) (1) Environmental Services1,219 50 1,169 4,118 2,517 1,601 Heavy Construction5 36 (31) 157 217 (60)Corporate(355)(197)(158) (968)(916)(52) 869 (111)980 3,307 1,818 1,489 Depreciation533 501 32 2,275 1,970 305 Financing expense396 206 190 1,124 803 321 Gain on disposal(159)- (159) (159)(483)324 Loss before tax99 (818)917 67 (472)539 Income tax expense- - - - - - Net income (loss)99 (818)917 67 (472)539 YEAR ENDED DECEMBER 31, 2020 Despite continued market challenges throughout 2020, Cordy's consolidated revenues increased by $2.2 million or 14 percent, from the comparative period in 2019 and operating earnings increased $1.5 million or 82 percent from the comparative period. The net result was a consolidated operating margin of 17.8% compared to 11.1% on 2019. Cordy’s improved performance was driven by strong first and fourth quarters. Primarily, a short-lived revival of the Oil & Gas sector in Western Canada, pre COVID-19 onslaught, drove the Q1 results, while infrastructure support services anchored the Q4 performance. In addition to the Q1 and Q4 performance, Cordy achieved the following: Closed acquisition of Platinum North Resources Ltd. and Heart River Holdings at the end of first quarter enhanced Cordy’s geographic reach and suite of environmental servicessoftened the impact on performance from COVID-19improved net-asset position Restructured lending agreements providing additional flexibility and cashflow for operations through COVID-19Strengthened the executive team adding new COO and CFOClosed Joint Venture agreement with indigenous owned company expanding Cordy’s opportunities in B.C. Overall, Cordy continued to show its resilience in 2020, increasing both revenue and income during unprecedented times. The COVID-19 outbreak caused major economic turmoil, including business interruption from government mandated shutdowns, and significant cuts in customer spending. While Cordy was not immune to the impacts of COVID-19, management made critical decisions in 2020, which helped offset the impact of COVID-19 on overall performance as compared to 2019. CORPORATE OUTLOOK In March 2020, the World Health Organization declared a global health pandemic due to COVID-19. Despite the near-term market uncertainty resulting from the ongoing COVID-19 pandemic, the Company’s fourth quarter continued to improve sequentially not only over the prior three quarters, but over the prior year. Cordy demonstrated incredible business resiliency in a year of unprecedented challenges for our industry and country. Cordy’s oilfield customers reactivated drilling programs albeit at a reduced level, early in the fourth quarter, and are expected to continue drilling programs through the end of the first quarter of 2021. The uncertainty around the prolonged effects of COVID-19, the timing and availability of the vaccinations, and strict lock-downs due to recent surges, and new more infectious variants, continue to provide the Company with challenges and any change in the current trends could significantly alter management’s expectations over the medium term. The timing of a full rebound in activity remains uncertain; however, the recent announcements showing safe, effective coronavirus vaccines, provide optimism for the continuation of gradual recovery over the next six to twelve months. The Company is continuing to evaluate its growth strategy while aggressively managing its costs and continuing to focus on the health and safety of its employees, contractors, and customers, ensuring it is doing its part in mitigating the spread, and limiting the impact of COVID-19. For general and investor relations information, please contact: Investor RelationsDarrick EvongChief Executive OfficerIR@cordy.caTel: 403-262-7667 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. READER ADVISORY This News Release contains certain statements that constitute forward-looking statements. These statements relate to future events or the Corporation’s future performance. All statements, other than statements of historical fact, that address activities, events or developments that the Corporation or a third party expects or anticipates will or may occur in the future, are forward-looking statements. These include the Corporation’s future growth, results of operations, performance and business prospects and opportunities; prevailing economic conditions; commodity prices; sourcing, pricing and availability of raw materials, components and parts, equipment, suppliers, facilities and skilled personnel; dependence on major customers; uncertainties in weather and temperature affecting the duration of the service periods and the activities that can be completed; regional competition; and other factors, many of which are beyond the Corporation’s control. These other factors include future prices of oil and natural gas and oil and natural gas industry activity, including the effect of changes in commodity prices on oil and natural gas exploration and development activity, the ability to complete strategic acquisitions and realize the anticipated benefits of any acquisitions that are completed, the Corporation’s outlook regarding the competitive environment it operates in, and the assumptions underlying any of the foregoing. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “plan”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “predict”, “potential”, “targeting”, “intend”, “could”, “might”, “should”, “believe” and similar expressions. These statements involve known and unknown risks, uncertainties and other factors, many of which are beyond the Corporation’s control, including those discussed under “Risks and Uncertainties” and elsewhere in this News Release, that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The Corporation believes that the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this News Release should not be unduly relied upon. These statements speak only as of the date of this News Release. The Corporation does not intend, and does not assume any obligation, to update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required under applicable securities laws. The forward-looking statements contained in this News Release are expressly qualified by this cautionary statement.
(Bloomberg) -- Japan’s key consumer prices fell at a slower pace in March for an eighth straight month of declines as pandemic-related business restrictions weighed on activity, underscoring the challenge the central bank faces as it tries to revive inflation.Consumer prices excluding fresh food edged down 0.1% from a year earlier, after a 0.4% decline in February, with smaller falls in energy costs helping narrow the drop, the ministry of internal affairs reported Friday. Economists had forecast a 0.2% decrease.Key InsightsPrime Minister Yoshihide Suga has recommended placing Tokyo, Osaka and other areas under another state of emergency due to rising infection cases. Prices may face additional weakness if consumer activity is further limited as a result of tougher restrictions.Inflation remains well below the Bank of Japan’s 2% target after the pandemic pushed prices in the opposite direction. With the likely time frame for achieving the goal pushed further into the future, the BOJ tweaked its stimulus framework last month to make it more sustainable, a move some economists saw as a step toward policy normalization.The central bank is set to update its growth and price forecasts on April 27 and they are likely to show for the first time that the BOJ won’t achieve its inflation goal during Governor Haruhiko Kuroda’s current term.What Bloomberg Economics Says...“Looking ahead, we expect core inflation to come back to around 0% in April due to base effects of energy prices, which fell sharply during the first virus wave last spring. But renewed virus-containment measures in April will probably keep a damper on inflation.”--Yuki Masujima, economistFor the full report, click here.Get MoreExcluding fresh food and energy, prices rose 0.3%, matching a forecast by analysts.Overall consumer prices fell 0.2%, in line with economists’ consensus.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Wealth manager AMP will spin off and list one of its key business units after a potential sale fell through.The private markets investment arm AMP Capital manages assets classes including infrastructure equity and debt and real estate.
The Biden administration wants to spend $174 billion to boost electric vehicles and charging stations but its 2030 climate emissions reduction pledge released on Thursday does not include a firm date to phase out gasoline-powered vehicles. McCarthy said the administration had not determined how much it wanted to see emissions reduced from the vehicle sector by 2030 or what percentage of zero-emission vehicles must be on the road by then.
British transport operator FirstGroup Plc is selling two North American-based bus units to funds managed by EQT Infrastructure for about $4.6 billion, Sky News reported https://bit.ly/3tJYGnH on Thursday. The deal, which Sky said would be announced on Friday, citing sources, exceeds earlier price expectations and will return millions of pounds to FirstGroup shareholders. Aberdeen-headquartered FirstGroup and EQT both declined to comment.
These are fraught days for Minneapolis – and the nation, writes Andrew Buncombe
(Bloomberg) -- Intel Corp., the biggest chipmaker, reported a drop in data center revenue and a steep decline in gross profit margin, a sign it’s losing market share to rivals and customers who are designing their own components.The PC business performed better on continued demand for laptops that run Intel processors. But the company’s Data Center Group generated first-quarter sales that fell 20% from a year earlier and missed Wall Street estimates. The unit is Intel’s most profitable businesses, so the lower revenue dented overall margins.New Chief Executive Officer Pat Gelsinger inherited a company that’s struggling with production technology that was once the foundation of its industry dominance. Delays have allowed other chip companies to catch up and tempted customers to design their own components. Intel argued the server business is going through a temporary slump caused by too much inventory. The first quarter was the bottom and growth has returned, executives said.That didn’t diffuse questions from analysts on a conference call focused on whether Intel is losing market share and when profitability will start to expand. Gelsinger said Intel is now in “investment mode” during a critical period for its return to leadership, and promised he’ll deliver products that are again the best in the industry.“The days of Intel having a stranglehold on this business have gone,” said Logan Purk, an analyst at Edward D Jones & Co. “The competitive landscape has shifted and it’s shifted quickly. That is going to weigh on this business.”Intel said its gross margin, the percentage of revenue remaining after deducting the cost of production, was 55.2%, down more than five percentage points from the same period in 2020. This is a key indicator of the strength of its manufacturing and product pricing. Intel has historically delivered margins above 60%.The shares fell about 2% in extended trading after closing at $62.57 in New York. Investors had been optimistic about Gelsinger’s recovery plan, pushing the stock up 26% this year through Thursday, after it declined 17% in 2020 and lagged far behind its rivals.The Santa Clara, California-based company raised its full-year sales forecast slightly to $72.5 billion. While that’s down from last year’s record $77.87 billion, the company still gets multiple billions of dollars more in sales than faster-growing Taiwan Semiconductor Manufacturing Co. and Samsung Electronics Co. Those companies though, have passed Intel in manufacturing technology and are spending heavily to maintain the gap with budgets the U.S. company will struggle to match, according to Purk of Edward D Jones.Amazon.com Inc. and other big cloud providers are designing more chips in-house for their data centers. These businesses have been major Intel customers for years, so the trend is a concern for the company and investors. Advanced Micro Devices Inc. has also rolled out more competitive data center processors recently.Read more: Amazon Is Designing Its Own Chips in Yet Another Blow to IntelIntel said sales of chips to cloud service providers fell 29% from the same period a year earlier. That huge drop, according to Intel, was caused by “digestion” -- customers pausing orders while they work through unused stockpiles of chips.While this has happened before and rebounds have followed, investors are increasingly concerned that delays in new Intel products have led this crucial group of customers to shop elsewhere and they won’t come back.Gelsinger’s revival plan is getting a boost from the PC market, though. The Covid-19 pandemic forced millions of people to work and study from home, driving a surge in purchases of laptops and other computer gear.Intel’s PC chip division had first-quarter revenue of $10.6 billion, up 8% from a year earlier. Analysts projected $10 billion.Gelsinger said there’s no sign of a slowdown in PC demand. The company’s 2021 forecast is constrained by supply shortages, while profitability is being squeezed as costs increase and the company competes aggressively to win market share, he added.“We are here to win and we’re going to be very competitive in our approach to gain market share,” he said.(Updates with analyst comment in the fifth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
The Victorian government has established a new fund to cover funeral expenses for members of the stolen generations.Aboriginal Affairs Minister Gabrielle Williams on Friday announced the $300,000 interim program, which will operate until a $10 million reparations scheme begins later in 2020.
Japan's core consumer prices fell 0.1% in March from a year earlier, marking the eighth straight month of annual declines, as the coronavirus pandemic weighs on household spending and the fragile economy. The drop in the core consumer price index (CPI), which includes oil products but excludes volatile fresh food prices, matched a median market forecast.
theScore Issues Statement Following the Passing of Bill C-218 by the House of Commons.
The midday decline came amid reports that the Biden administration would propose tax increases on high-income taxpayers. The proposal targets a provision that long-term investors have taken advantage of for decades: the favorable tax rate on capital gains, the profits they realize when they sell stocks or other investments. What taxes could go up, and on whom?
Headline of release should read: School Support Staff Appreciate Decisive Action to Close 32 Schools in Nova Scotia (instead of School Support Staff Appreciate Decisive Action to Close 38 Schools in Nova Scotia). Also, first paragraph should read ..closing 32 schools... (instead of ...closing 38 schools...).
Diabacore from Thomas Sully is a hailed as a type 2 diabetes breakthrough that works to provide healthy ingredients to lower blood sugar and naturally break free from type 2 diabetes, but are there negative side effects or is it actually worth the money? Diabacore Reviews Diabacore Reviews New York, NY, April 22, 2021 (GLOBE NEWSWIRE) -- For millions of people around the world, diabetes is a life-changing issue that will haunt them for the rest of their lives. Years and years on insulin shots, medical consultations, and life-threatening side effects lead many down a dark path to depression or resignation. According to a report found on diabetes.org, more than 10% of Americans, or 34 million have been diagnosed or are projected to have diabetes. This means that you or someone close to you likely has diabetes and has to deal with its physical and financial burdens for years to come. As the cost of treatment for diabetes, specifically life-saving insulin shots, continues to be an expensive dose of reality for the millions of Americans who want to continue to live healthy with diabetes, however, the question on everyone’s mind is, can anything be done to treat diabetes that doesn’t require expensive and invasive medical procedures? For those who are tired of having to deal with diabetes and prick themselves every day, there may be a solution that could help you control your blood sugar, increase your body’s natural production of insulin, and maybe even get your diabetes under control. The creators of Diabacore claim that their new supplement contains a formula that can help treat and even reverse type two diabetes. This is a bold claim and we suggest that if you decide to use Diabacore or any supplement that you continue to take your prescribed treatment and consult your doctor before making any major changes to your lifestyle that could affect your health. Diabacore has a disclaimer on its website that its products aren’t intended to diagnose, treat, cure or prevent any disease on its own, so keep that in mind. With that being said, can Diabacore actually help treat type two diabetes? Or is it promising something that it can’t deliver? We thought it would be best to look into this reported solution and have found some interesting information about Diabacore that anyone with type two diabetes should be interested in. What Does Diabacore Do? The premise of Diabacore is simple, to help those suffering from diabetes, specifically type 2 diabetes control their insulin levels naturally and eventually reverse the effects of diabetes. It does this through a daily supplement that’s designed to combat insulin resistance by changing the way that your hormones interact with your body’s natural insulin production. The pancreas is responsible for your body’s ability to produce and absorb insulin, the hormone in your body that lowers the level of glucose in your blood. When insulin stops being produced in normal amounts, your body loses the ability to fully absorb the glucose in your blood. This causes high blood sugar levels, which over time leads to significant, life threatening effects to your health. The ingredients in Diabacore are all primarily designed to reduce the body’s blood sugar levels and treat hormone imbalances through vitamins and other nutrients naturally found around the world. With Diabacore, insulin production could start to return to normal as the hormonal imbalances in your digestive system are reduced. Your blood sugar levels could also return to pre-diabetic ranges placing you in a state of “complete remission” without having to undergo invasive and costly surgery. Here’s a list of some of the ingredients in Diabacore, and the impacts they’re reported to have on the body. Commiphora Mukul (Guggul) This herbal medicine used in Asia for centuries has been shown to reduce blood sugar levels, treating some of the effects of type 2 diabetes. Bitter Melon This acts as a sort of replacement for insulin that will help your body absorb the glucose trapped in your blood. It’s said to be a great way to reduce blood sugar while also increasing energy. Licorice Root Yes, the core ingredient of licorice candy, has actually been linked to anti-inflammatory molecules that also help to reduce blood sugar. Banaba Found in Asia, this powerful plant helps to lower blood sugar levels and is also an antioxidant that can help with cholesterol, protect your kidney from damage, and even reduce weight gain. Gymnema Sylvestre Another plant found in Asia and Australia that’s supposed to help reduce your natural cravings for sugar and also has a positive effect on reducing blood sugar and cholesterol. Biotin A natural vitamin that helps your body transform nutrients into energy, this helps manage the hormonal imbalance in your body caused by lack of good nutrition. There are thirteen more ingredients in Diabacore which have been studied and shown to have an effect on your digestive health and ability to absorb glucose in your blood. These include powerhouses like Vitamin C, Magnesium, Zinc, Vitamin E, and more. How Much Do All of These Ingredients Cost? According to the Diabacore website, incorporating this wide range of powerful plants, vitamins, and nutrients on your own would cost more than $500 a week. Many of these are found in far off places, difficult to ship worldwide in their edible form. Instead, the creators of Diabacore found a way to extract them through an inexpensive and easy to produce process. Their natural blend of all natural, non-GMO, and safe ingredients is now available for as low as $49 a bottle. (HUGE SAVINGS TODAY) Click Here to Get Diabacore Supplement For The Lowest Price Right Now How Was Diabacore Created? Diabacore is the product of extensive research and many doctors who they claim have been shunned by big pharma for threatening to make the multi-billion dollar diabetes industry go broke through their inexpensive treatments. Dr. Thomas Sully is cited as the man who made Diabacore possible and called “Big Pharma’s most hated man.” He claims to have found the formula for an inexpensive and effective way to help treat type 2 diabetes after extensive research into more than 69 prospective ingredients found around the world. He accuses the pharmaceutical industry of holding back research that could cure or treat diabetes because of the large sums of money that they continue to make by selling expensive treatments. (SPECIAL OFFER) Click Here to Get Diabacore with an Exclusive Discount Price Online One story that he cites is of Dr. Denise Faustman, a renowned researcher who claimed to find a vaccine for type 2 diabetes. Rather than approve clinical tests, the pharmaceutical industry stalled her research for more than 19 years. She is still waiting for approval to test her vaccine which could help save millions of lives in the future. Another researcher, Professor Irving Weissman, developed a novel treatment for type 2 diabetes involving stem cells. Like Dr. Faustman, his research was refused funding and access to clinical trials which forced him to abandon his promising research. Dr. Sully claims that the way to treat and even cure type 2 diabetes has been found multiple times, but each time has been suppressed by shady profiteers. This is the reason that he thinks his supplement has been largely unseen by the general public. Despite that, over 119,000 people who have suffered from type 2 diabetes have found relief in Diabacore through the diabacore.com website and product page. How Can You Purchase Diabacore? You can find Diabacore exclusively on their website, diabacore.com along with customer testimonials, the scientific research behind their product, and a secure checkout where you can purchase Diabacore. When you open the webpage you’ll be treated with a video that outlines how Diabacore can help you treat your type 2 diabetes without having to take potentially dangerous drugs or undergo invasive surgery. At the bottom of the page is an option to purchase Diabacore in packages of 1, 3, or 6 bottles. Each bottle holds a standard one-month supply of daily supplements. While their single bottle is available for $69 and serves as a great introduction to Diabacore the other options offer reduced prices per bottle to give you more value. The three bottle supply is their most popular option and costs $177, or $59 a bottle. When you buy a bundle of 6 bottles for $294, you can save $300 making it their best valued option. You only pay $49 with this option and save $20 a bottle. The Diabacore website often gives promotional discounts to new customers looking to try Diabacore. But it also stresses that due to the high demand and sought after ingredients quantities are limited. In fact, they place a warning that their product can only be produced in batches every 3 months. This means that at any time the product could immediately become unavailable and stay that way for months at a time. If you’re interested in purchasing Diabacore they make sure that you won’t pay for a product that doesn’t work and guarantee your satisfaction through a 60 day, no questions asked, money back guarantee. Diabacore could offer relief for those suffering from type 2 diabetes thanks to some powerful ingredients that are reported to lower blood sugar and deliver needed nutrients to your body. The security advertised on their website and money back guarantee along with discounts for new customers make it worth looking into even if you’re skeptical of its claims to treat and even reverse type 2 diabetes. (LOWEST PRICE ONLINE) Get Diabacore Directly from the Official Website for the Biggest Discount Official Website: https://diabacore.com/report Contact Details: Diabacore Email: firstname.lastname@example.org About MarketingByKevin.com This product review is published by Marketing By Kevin. Marketing By Kevin reviews are researched and formulated by a group of experienced natural health advocates with years of dedication and determination to finding the highest quality health products and wellness programs available. It should be noted that any purchase derived from this resource is done at your own peril. It is recommended to consult with a qualified professional healthcare practitioner before making an order today if there are any additional questions or concerns. Any order finalized from this release’s links are subject to the entire terms and conditions of the official website’s offer. The researched information above does not take any direct or indirect responsibility for its accuracy. Affiliate Disclosure: The links contained in this product review may result in a small commission to Marketing By Kevin if you opt to purchase the product recommended at no additional cost to you. This goes towards supporting our research and editorial team and please know we only recommend high quality products. Disclaimer: Please understand that any advice or guidelines revealed here are not even remotely a substitute for sound medical advice from a licensed healthcare provider. Make sure to consult with a professional physician before making any purchasing decision if you use medications or have concerns following the review details shared above. Individual results may vary as the statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. Product support: email@example.com Media Contact: firstname.lastname@example.org Attachment Diabacore Reviews CONTACT: Kevin Mahoney 708-247-1324 email@example.com
The Japanese government is seeking a "short and powerful" state of emergency for Tokyo, Osaka and two other prefectures, a cabinet minister says, as Japan struggles to contain a resurgent pandemic.Under a new state of emergency issued for April 25 to May 11, the government would ask restaurants, bars, and karaoke parlours serving alcohol to close, and big sporting events to be held without spectators, Economy Minister Yasutoshi Nishimura said.
(Bloomberg) -- Stocks look set to slip in Asia Friday following broad-based declines in U.S. benchmarks as investors mulled a proposal for higher taxes on the wealthy to help pay for President Joe Biden’s social plan.Futures pointed lower in Japan, Hong Kong and Australia. U.S. contracts edged up after the steepest decline in five weeks for the S&P 500 Index. Speculation arose that traders may sell shares preemptively as Bloomberg News reported the Biden administration is considering raising the tax on capital gains to 39.6% for those earning more than $1 million a year.Treasury yields dipped overnight and the dollar was steady in early Asia trade.“For the short term most likely we’ll continue to see volatility as investors will use the current environment to capture gains,” said Teresa Kong, portfolio manager at Matthews International Capital Management, LLC.Investors are weighing the implications of higher taxes against the potential growth benefits of a spending program focused on infrastructure. Markets are also whipsawing on worsening news about the spread of Covid-19 in parts of the world and a mixed batch of earnings reports.AT&T Inc. jumped Thursday after beating earnings estimates, while Intel Corp. -- the biggest chipmaker -- slid after hours as it reported a drop in data-center revenue and a slump in gross profit margin.Markets were little moved overnight by further assurance from European Central Bank President Christine Lagarde that the institution isn’t discussing any pullback in its emergency bond buying program even as economic data improve.Elsewhere, Bitcoin steadied after declining for the sixth time in seven days. Investors already face a capital-gains tax if they hold the cryptocurrency for more than a year. Oil gained on strengthening demand signals from key economies.The U.S. releases new home sales data later on Friday.These are some of the main moves in markets:StocksS&P 500 futures climbed 0.1% as of 8:25 a.m. in Tokyo. The S&P 500 fell 0.9% Thursday.Nikkei 225 futures were down 0.8%.Hang Seng futures slipped 0.1% earlier.S&P/ASX 200 futures slid 0.2%.CurrenciesThe Bloomberg Dollar Spot Index was steady.The euro traded little changed at $1.2016.The Japanese yen was flat at 107.96 per dollar.BondsThe yield on 10-year Treasuries fell about two basis points to 1.54%.CommoditiesWest Texas Intermediate rose 0.7% to $61.87 a barrel.Gold was little changed at $1,784 an ounce.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
UNP earnings call for the period ending March 31, 2021.
Image source: The Motley Fool. Site Centers Corp (NYSE: SITC)Q1 2021 Earnings CallApr 22, 2021, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood morning, and welcome to the SITE Centers' First Quarter 2021 Operating Results Conference Call.